New Study: Epigenetics Market Expected to Grow $1,321 Mn by 2023 - Allied Market Research

"Epigenetics offers advanced cancer therapies and is expected to become one of the most effective treatment options for disease, especially cancer in the future. Increased awareness of posterior sexual factors and their role in developmental and disease biology are expected to create profitable opportunities in the expected period."

A new report "Epigenetics Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023", published by Allied Market Research. The global epigenetics market was valued at $555 million in 2016, and is projected to reach $1,321 million by 2023, growing at a CAGR of 13.1% from 2017 to 2023. The DNA-modifying enzymes segment witnessed the highest rate, generating maximum revenue in the market in 2016.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/846

Epigenetics is a field of developmental biology that studies changes in cell and physiological characteristics that have begun from an external or ecological perspective. This external stimulus turns the gene on and off and affects the ability of the cell to read the gene. Epigenetics changes the organism phenotype rather than genotype, and the base DNA or RNA sequence does not change. For example, DNA methylation and histone modification are posterior processes such as altered gene expression that is not observed in the DNA sequence. The increased use and application of epigenetics to formulate drugs to treat various oncology and non-oncology related diseases is expected to drive market growth.

The major factors that drive the global epigenetics market are rise in cancer prevalence; improved funding & aids for R&D activities, surge in partnership between academic, pharmaceutical, and biotechnology companies, and increased application of epigenetics in non-oncology diseases. However, high cost of instruments and lack of trained professionals are factors that impede the growth of this market. Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players.

The kits & assays product segment occupies the highest share in epigenetics product market, owing to their sheer usage and need throughout the protocol and other pre-requisite steps of DNA analysis. The next-generation sequencers segment witnessed the highest growth rate, and accounted for over half of the total share in 2016, and is anticipated to dominate the market. This is attributed to most of the epigenetic investigations that utilize this technology to achieve their desired objective.

At present, oncology dominates the application segment and is expected to grow at a CAGR of 12.8% during the forecast period. Drugs based on epigenetics are reported to be incredibly effective and aid reverse abnormal gene expression. Abnormal gene expression causes an array of different diseases, especially cancer and respiratory diseases.

Key Findings of the Epigenetics Market:

• The kit & assays product segment is anticipated to grow at the highest CAGR from 2017 to 2023.
• The oncology application segment is expected to witness the highest growth rate during the forecast period.
• The academic & government research institutes segment generated the highest revenue in 2016, and is expected to continue its dominance in the near future.
• North America dominated the global epigenetics market, and is projected to grow at a CAGR of 12.3%.
• Asia-Pacific is expected to witness the highest growth rate during the forecast period.

The major companies profiled in the report include Abcam plc., Illumina, QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif. Diagenode, Inc., and Zymo Research Corporation.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/846

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.